belnacasan (VX-765) - Vertex
pirfenidone - Generic mfg.
Kineret (anakinra) - SOBI
Ilaris (canakinumab) - Novartis
nintedanib - Generic mfg.
Decoding Pyroptosis in Pulmonary Fibrosis: Molecular Mechanisms and Therapeutic Horizons. (PubMed, Curr Pharm Des) - Oct 21, 2026 - "Targeting the pyroptosis signaling axis offers a promising strategy for reversing PF progression. Future research should prioritize the identification of pyroptosis- related biomarkers and the development of lung-targeted delivery systems to facilitate clinical translation and precision intervention." 
IO biomarker • Journal • Fibrosis • Immunology • Interstitial Lung Disease • Oncology • Pulmonary Disease • Respiratory Diseases
http://www.ncbi.nlm.nih.gov/pubmed/42897801
 
Boyang Yu; Chunlei Hua; Haibin Wang; Lixin Zhao; Minhui Li; Shuqi Zheng; Tuya Xilin; Wanze Feng; Zengxia Liu
 
Oct 21, 2026
 
Prev Next